A report by experts released by the Food and Drug Administration (FDA) on Monday raised doubts as to whether the vaccine developed by United Biomedical Inc (UBI) Asia offers sufficient protection against COVID-19 variants.
According to the report, a panel of 22 experts at a review meeting on Aug. 15, which denied a request from UBI for emergency use authorization (EUA) for its vaccine candidate UB-612, suggested that the company should conduct a third phase of clinical trials to determine the jab’s efficacy.
At the meeting, 17 of the experts, not counting the chairman, voted against UBI’s request for an EUA, as the vaccine candidate failed to meet approval standards, while the remaining four asked the company to submit more documents for another review.
For a vaccine to be granted an EUA by the FDA, it has to have a seroconversion rate of more than 50 percent and virus neutralizing antibodies — expressed as geometric mean titers (GMTs) — at least equal to two-thirds the level found in recipients of the AstraZeneca vaccine.
UBI has said that its vaccine candidate is expected to protect those inoculated against the Delta variant of SARS-CoV-2, which is now the most transmittable and contagious variant worldwide.
However, the report said that the GMT of UBI’s vaccine candidate declined at a moderate pace when faced with virus variants and based on the limited information available it is hard to say whether people who receive the vaccine would be protected against the Delta and Alpha variants.
The report also cited some experts on the panel as saying that UBI’s vaccine did not even appear to be effective against the original SARS-CoV-2 virus.
However, some other experts on the panel said that peptides inside the vaccine still have the potential to create protection against variants of SARS-CoV-2, suggesting that UBI should conduct a third phase 3 clinical trial.
They added that it remains to be seen how the vaccine creates a response to T-cells.
On Aug. 22, UBI founder Wang Chang-yi (王長怡) said that the FDA’s standards for granting EUAs were hastily designed and outdated.
She said that it would be deeply regrettable to deny people access to such a good vaccine because of hastily devised EUA standards.
Despite its application being rejected in Taiwan, UBI remains committed to seeking international approval for its COVID-19 vaccine candidate, Wang said.
The company plans to conduct phase 3 clinical trials in India for its “next generation” COVID-19 vaccine, named “UB-613,” she said.
The FDA decided to test antibody concentrations against people who have been immunized with the AstraZeneca vaccine because there is no uniform, globally accepted method of measuring GMTs or how high the GMT level should be to indicate protection.
The Grand Hotel Taipei on Saturday confirmed that its information system had been illegally accessed and expressed its deepest apologies for the concern it has caused its customers, adding that the issue is being investigated by the Ministry of Justice Investigation Bureau. The hotel said that on Tuesday last week, it had discovered an external illegal intrusion into its information system. An initial digital forensic investigation confirmed that parts of the system had been accessed, it said, adding that the possibility that some customer data were stolen and leaked could not be ruled out. The actual scope and content of the affected data
DO THEY BITE IT? Cats have better memories than people might think, but their motivation is based entirely around the chance of getting fed Cats can remember the identity of the people who fed them the day before, Taipei-based veterinarians said on Friday, debunking a popular myth that cats have a short memory. If a stray does not recognize the person who fed them the previous day, it is likely because they are not carrying food and the cat has no reason to recognize them, said Wu Chou Animal Hospital head Chen Chen-huan (陳震寰). “When cats come to a human bearing food, it is coming for the food, not the person,” he said. “The food is the key.” Since the cat’s attention is on the food, it
A New York-based NGO has launched a global initiative to rename the nation’s overseas missions, most of which operate under the name "Taipei," to "Taiwan Representative Office (TRO)," according to a news release. Ming Chiang (江明信), CEO of Hello Taiwan, announced the campaign at a news conference in Berlin on Monday, coinciding with the World Forum held from Monday through Wednesday, the institution stated in the release. Speaking at the event, Democratic Progressive Party Legislator Huang Jie (黃捷) said she believed this renaming campaign would enable the international community to see Taiwan
TOO DANGEROUS: The families agreed to suspend crewed recovery efforts that could put rescuers in danger from volcanic gases and unstable terrain The bodies of two Taiwanese tourists and a Japanese pilot have been located inside a volcanic crater, Japanese authorities said yesterday, nearly a month after a sightseeing helicopter crashed during a flight over southwestern Japan. Drone footage taken at the site showed three bodies near the wreckage of the aircraft inside a crater on Mount Aso in Kumamoto Prefecture, police and fire officials said. The helicopter went missing on Jan. 20 and was later found on a steep slope inside the Nakadake No. 1 Crater, about 50m below the rim. Authorities said that conditions at the site made survival highly unlikely, and ruled
RSS